188 related articles for article (PubMed ID: 7510235)
1. Reversal of hyporesponsiveness in lpr CD4-CD8- T cells is achieved by induction of cell cycling and normalization of CD2 and p59fyn expression.
Clements JL; Wolfe J; Cooper SM; Budd RC
Eur J Immunol; 1994 Mar; 24(3):558-65. PubMed ID: 7510235
[TBL] [Abstract][Full Text] [Related]
2. CD2 expression correlates with proliferative capacity of alpha beta + or gamma delta + CD4-CD8- T cells in lpr mice.
Budd RC; Russell JQ; van Houten N; Cooper SM; Yagita H; Wolfe J
J Immunol; 1992 Feb; 148(4):1055-64. PubMed ID: 1346621
[TBL] [Abstract][Full Text] [Related]
3. Co-stimulation via CD28 induces activation of a refractory subset of MRL-lpr/lpr T lymphocytes.
Clements JL; Winslow G; Donahue C; Cooper SM; Allison JP; Budd RC
Int Immunol; 1993 Nov; 5(11):1451-60. PubMed ID: 7903158
[TBL] [Abstract][Full Text] [Related]
4. Intact antigen receptor-mediated generation of inositol phosphates and increased intracellular calcium in CD4 CD8 T lymphocytes from MRL lpr mice.
Budd RC; Winslow G; Inokuchi S; Imboden JB
J Immunol; 1990 Nov; 145(9):2862-72. PubMed ID: 1976707
[TBL] [Abstract][Full Text] [Related]
5. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
Giese T; Allison JP; Davidson WF
J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618
[TBL] [Abstract][Full Text] [Related]
6. CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursor.
Landolfi MM; Van Houten N; Russell JQ; Scollay R; Parnes JR; Budd RC
J Immunol; 1993 Jul; 151(2):1086-96. PubMed ID: 7687614
[TBL] [Abstract][Full Text] [Related]
7. The proliferative in vivo activities of lpr double-negative T cells and the primary role of p59fyn in their activation and expansion.
Balomenos D; Rumold R; Theofilopoulos AN
J Immunol; 1997 Sep; 159(5):2265-73. PubMed ID: 9278315
[TBL] [Abstract][Full Text] [Related]
8. The expanded populations of CD4-CD8- T cell receptor alpha/beta+ T cells associated with the lpr and gld mutations are CD2-.
Shirai T; Abe M; Yagita H; Okumura K; Morse HC; Davidson WF
J Immunol; 1990 May; 144(10):3756-61. PubMed ID: 1970592
[TBL] [Abstract][Full Text] [Related]
9. Intestinal intraepithelial lymphocyte T cells are resistant to lpr gene-induced T cell abnormalities.
Aicher WK; Fujihashi K; Taguchi T; McGhee JR; Yamamoto M; Eldridge JH; Gay S; Kiyono H
Eur J Immunol; 1992 Jan; 22(1):137-45. PubMed ID: 1346108
[TBL] [Abstract][Full Text] [Related]
10. Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for lpr.
Giese T; Davidson WF
J Immunol; 1992 Nov; 149(9):3097-106. PubMed ID: 1383337
[TBL] [Abstract][Full Text] [Related]
11. Maturational changes in CD4+ cell subsets and lymphokine production in BXSB mice.
Chu EB; Ernst DN; Hobbs MV; Weigle WO
J Immunol; 1994 Apr; 152(8):4129-38. PubMed ID: 7511669
[TBL] [Abstract][Full Text] [Related]
12. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD
J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246
[TBL] [Abstract][Full Text] [Related]
13. Parallels in T lymphocyte development between lpr and normal mice.
Budd RC; Van Houten N; Clements J; Mixter PF
Semin Immunol; 1994 Feb; 6(1):43-8. PubMed ID: 8167306
[TBL] [Abstract][Full Text] [Related]
14. The role of the interleukin-2 (IL-2)/IL-2 receptor pathway in MRL/lpr lymphadenopathy: the expanded CD4-8- T cell subset completely lacks functional IL-2 receptors.
Tanaka T; Nagasaka Y; Kitamura F; Kuida K; Suwa H; Miyasaka M
Eur J Immunol; 1993 Jun; 23(6):1378-80. PubMed ID: 7684688
[TBL] [Abstract][Full Text] [Related]
15. Mitogen-induced IL-2 production and proliferation at defined stages of T helper cell development.
Chang JF; Thomas CA; Kung JT
J Immunol; 1991 Aug; 147(3):860-6. PubMed ID: 1830601
[TBL] [Abstract][Full Text] [Related]
16. The expression and regulation of c-myb transcription in B6/lpr Lyt-2-, L3T4-T lymphocytes.
Yokota S; Yuan D; Katagiri T; Eisenberg RA; Cohen PL; Ting JP
J Immunol; 1987 Oct; 139(8):2810-7. PubMed ID: 3116095
[TBL] [Abstract][Full Text] [Related]
17. A model for the origin of TCR-alphabeta+ CD4-CD8- B220+ cells based on high affinity TCR signals.
Mixter PF; Russell JQ; Morrissette GJ; Charland C; Aleman-Hoey D; Budd RC
J Immunol; 1999 May; 162(10):5747-56. PubMed ID: 10229807
[TBL] [Abstract][Full Text] [Related]
18. Subpopulations of CD4+ cells in lpr/lpr mice: differences in expression of T cell receptor/CD3 complex and proliferative responses.
Asano T; Yoshikai Y; Matsumoto K; Matuzaki G; Nomoto K
Clin Exp Immunol; 1990 Jul; 81(1):90-6. PubMed ID: 1696186
[TBL] [Abstract][Full Text] [Related]
19. Suppression of autoimmune disease and of massive lymphadenopathy in MRL/Mp-lpr/lpr mice lacking tyrosine kinase Fyn (p59fyn).
Takahashi T; Yagi T; Kakinuma S; Kurokawa A; Okada T; Takatsu K; Aizawa S; Katagiri T
J Immunol; 1997 Sep; 159(5):2532-41. PubMed ID: 9278347
[TBL] [Abstract][Full Text] [Related]
20. Abnormal regulation of the IL-2 promoter in lpr CD4-CD8- T lymphocytes results in constitutive expression of a novel nuclear factor of activated T cells-binding factor.
Clements JL; Cooper SM; Budd RC
J Immunol; 1995 Jun; 154(12):6372-81. PubMed ID: 7759875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
